Burnham scientist outlines ambitious development plans

As the Burnham Institute for Medical Research in Florida moves from temporary digs into a new, 178,000-square-foot facility, its top scientists have been stepping up their recruitment of fresh talent.

Scientific director Dr. Daniel Kelly told an Orlando business group that Burnham's east coast campus will grow from a dozen lead scientists and 75 staffers to 30 top scientists and 300 workers by 2016. As new researchers are added to the staff, the business model calls for more partnerships with local hospitals and universities. And new ventures will be spun off into an area incubator.

Drug development is a top priority, he says. "We've had a number of important conversations with big pharma groups," Kelly told the crowd.

- read the story from the Orlando Business Journal

Suggested Articles

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.

Selectively targeting TGF-beta1 with Scholar Rock's SRK-181 overcame primary resistance to checkpoint inhibitor therapy in mice.

Enhertu produced a 55.6% objective response rate in HER2-positive non-small cell lung cancer patients in a phase 1 trial.